Neurodevelopmental disorder Neurodevelopmental Disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. patients with a diagnosis of Autism Spectrum Disorder (ASD) made by a pediatrician or psychiatrist using the DSM-5 (The Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders). Manual of Mental Disorders) by a pediatrician or psychiatrist. 2. have no organic abnormalities on MRI within 2 years prior to rTMS and have not previously been found to have epilepsy or afebrile seizures 3. Patients must have an intellectual quotient (IQ) of 60 or higher 4. right-handed diagnosed by the Edinburgh Handedness Inventory. 5. who are of age 8 to 30 years at the time of consent. 6. have been fully informed of the study and have provided informed consent from their parents or guardians and written assent from the patients themselves.
Exclusion criteria
Exclusion criteria: 1. those with metal present in the head other than the mouth. 2. those with a history of cardiac disease, gastrointestinal disease, chronic kidney disease, head trauma, or brain tumor. 3. those who have received a cardiac pacemaker, deep brain electrical stimulator, spinal cord stimulator, or drug therapy pump implantation. 4. those who have an organic abnormality in the cranium. 4. those with intracranial organic abnormalities (due to increased risk of seizure induction) 5. who have a history of convulsive disorders (febrile convulsions, epileptic seizures, epilepsy) 6. pregnant woman 7. who are deemed inappropriate by the responsible or subcontracting physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Number of cases which completed the treatment protocol 2) Number, frequency and severity of adverse events | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Change from baseline in questionnaire scores of sensory abnormality and social responsiveness 2) APD test score | — |
Contacts
The University of Osaka Hospital